Women (n=5698) | Men (n=3803) | |||||
Normoglycemia (n=4468) | Impaired fasting glucose (n=634) | Type 2 diabetes mellitus (n=596) | Normoglycemia (n=2753) | Impaired fasting glucose (n=570) | Type 2 diabetes mellitus (n=480) | |
Age, mean (SD) | 63.8 (9.8) | 67.0 (9.6) | 68.3 (10.3) | 62.7 (9.2) | 64.1 (8.3) | 65.5 (9.0) |
BMI, kg/m2, mean (SD) | 26.8 (4.3) | 29.0 (5.0) | 30.2 (5.2) | 26.5 (3.3) | 28.0 (3.6) | 28.7 (4.4) |
Prevalent overweight/obese (BMI ≥25 kg/m2), n (%) | 2777 (62.2) | 509 (80.3) | 508 (85.2) | 1830 (66.5) | 468 (82.1) | 382 (79.6) |
Hypertension,* n (%) | 2392 (53.5) | 472 (74.4) | 479 (80.4) | 1499 (54.4) | 410 (71.9) | 387 (80.1) |
Hypertension medication, n (%) | 1184 (26.5) | 260 (41.0) | 315 (52.9) | 607 (22.0) | 184 (32.3) | 215 (44.8) |
Total cholesterol, mmol/L, mean (SD) | 5.9 (1.0) | 5.9 (0.9) | 5.7 (1.0) | 5.6 (0.9) | 5.7 (1.0) | 5.3 (1.1) |
HDL-cholesterol, mmol/L, mean (SD) | 1.6 (0.4) | 1.5 (0.4) | 1.3 (0.4) | 1.3 (0.3) | 1.2 (0.3) | 1.1 (0.3) |
Lipid-lowering medication, n (%) | 628 (14.1) | 124 (19.6) | 139 (23.3) | 366 (13.3) | 82 (14.4) | 128 (26.7) |
P values for all cardiovascular risk factors for both women and men were significant at <0.001.
*Hypertension was defined as systolic blood pressure of ≥140 mm Hg and/or diastolic blood pressure of ≥90 mm Hg and/or a current prescription for antihypertensive medication.
BMI, body mass index; HDL, high-density lipoprotein.